ARG2 and metabolic syndrome: A recent study showed that the induction of ARG2 would promote the growth of pancreatic ductal adenocarcinoma, by directing metabolic nitrogen flow into the urea cycle; this condition could be increased by obesity and metabolic syndrome, characterized by an overabundance of nutrients [31].